Covington Represented UniQure in Sale of Gene Therapy Manufacturing Facility to Genezen
July 24, 2024
July 24, 2024
WASHINGTON, July 24 -- Covington, a law firm, issued the following news release:
Covington represented uniQure, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, in the sale of its Lexington, Massachusetts manufacturing facility to Genezen, a leading contract development and manufacturing organization specializing in the supply of retroviral vectors, lentiviral vectors, and adeno-associated virus (AAV) technologies.
Covington represented uniQure, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, in the sale of its Lexington, Massachusetts manufacturing facility to Genezen, a leading contract development and manufacturing organization specializing in the supply of retroviral vectors, lentiviral vectors, and adeno-associated virus (AAV) technologies.